Compare Humana Inc (HUM) vs iShares International Treasury Bond ETF (IGOV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs iShares International Treasury Bond ETF — how do they compare? Humana Inc trades at $374.25 (market cap $46.31B), while iShares International Treasury Bond ETF trades at $41.25. The key difference: Humana Inc pays a 0.92% dividend while iShares International Treasury Bond ETF pays none, and Humana Inc is trading nearer its 52-week high, iShares International Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.
| HUM | IGOV | |
|---|---|---|
Market Cap | $46.31B | — |
Sector | Health | — |
52-Week High | $409.42 | $43.09 |
52-Week Low | $163.67 | $40.35 |
Enterprise Value | $53.67B | — |
Dividend Yield | 0.92% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
IGOV trades at $41.45, up 0.44% today, with a bullish technical signal from moving averages. The stock shows neutral oscillator readings, with the 6-day relative strength index at 71.27 indicating potential overbought conditions. Support and resistance cluster near $41-$42, suggesting tight price consolidation. Recent news highlights downside risks from global bond sell-offs affecting the ETF's duration exposure.
The outlook balances technical strength against fundamental headwinds from rising interest rates. Investment opportunity lies in trend continuation if bullish momentum holds, but risks include capital loss amplification from high duration in inflationary environments. Investors should weigh technical buy signals against macroeconomic pressures on bond ETFs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About iShares International Treasury Bond ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index and will invest at least 90% of its assets in fixed income securities included in the underlying index. The underlying index measures the performance of fixed-rate, local currency, investment-grade, sovereign bonds from certain developed markets. The fund is non-diversified.
Read more on IGOV →
